new-adhd-medication-rules-brain-science-common-sense-1. 2 ["Account Type","Format"] == ["Account Type","Format"] new-adhd-medication-rules-brain-science-common-sense-2. 2 ["Account Type","Format"] == ["Account Type","Format"]

New ADHD Medication Rules: Brain Science & Common Sense

by Dr. Charles Parker

Save 26%

$14.95

$10.99

Account Type

Format

Quantity

Author: Dr. Charles Parker

Publisher: Koehler Books

Paperback:
ISBN 10: 1938467221
ISBN 13: 978-1938467226

New Rules Provides Solutions For ADHD Medication Confusion
Medical treatment for ADHD fails far too often - not because of the drugs themselves, but how they are managed. New ADHD Medication Rules -- Brain Science & Common Sense shows that patients often suffer from missed brain and body diagnoses that create a variety of reactions to ADHD medications. The too frequent result of these challenges: diagnostic confusion, imbalanced treatment and over or under medication. In the only book of its kind, Dr. Charles Parker clearly explains how these uncertainties happen, and how insightful communication with professionals can dramatically improve treatment using available methods assembled from hard data, clinical experience and laboratory research.

What You Will Learn From New ADHD Medication Rules:

Stimulant medication duration, "burn rates," depend on how the brain reacts to specific stimulant medications and to medical challenges in the body, such as nutrition and immunity. These imbalances affect brain function, and ultimately create unpredictable reactions to ADHD medications.
Treatment is not on par with easily understandable brain science. Brain science employs precise ADHD guideposts to remove much of the guesswork around diagnosis and treatment.
Few, if any, rules or protocols are available to practitioners for the daily clinical management of ADHD medications. Without specific rules patients face a standard-of-practice quagmire based upon inadequate treatment targets.

According to Parker: "Too many aren't thinking critically about medical treatments for the thinking process. ADHD is a diagnosis based upon appearances, not brain function."

Understandable Solutions
In straightforward language that simplifies the mind/body complexity of ADHD medical management, New ADHD Medication Rules offers clinical data and explanations for why treatments so often fail. Using irrefutable research about brain and body responses to ADHD meds, Dr. Parker outlines New Rules - practical treatment protocols - to customize treatment for each patient, and thereby design more predictable outcomes.

New Rules Objectives
Written for patients, parents of children with ADHD, and professionals, this book compels us to pay better attention to the drugs for paying attention.

Both paperback and Kindle editions are now available at Amazon.

Review

Awaiting specific reviews.

From the Author

I organized New ADHD Medication Rules after years of picking up the pieces during difficult second opinions in my office - both from my own treatment failures and my colleagues who missed aspects of the medication treatment process. To this day far too many simply write for ADHD meds without remotely thinking about the complexity, the details or the long term implications of medication management.

New Rules translates available Brain Science into Common Sense applications.

New ADHD Medication Rules reports understandable, data driven standards that arise directly from the extensive literature on medications, and from the newest information on brain imaging, immune system challenges, metabolic problems and simple genetic issues that often go overlooked when using ADHD meds. Symptom targets need improvement, and dosage strategies need far more precise attention.

I've taught other medical professionals to use New Rules medication protocols for ADHD medications since 1996 all across the USA - from LA and Seattle, to NYC, Boston San Francisco and Chicago, and know that they work because I've updated and self-corrected these New Rules regularly as fresh brain science discoveries emerged. From functional SPECT brain imaging to neurotransmitter measurements, to understanding immunity challenges such as gluten and casein, neuroscience discoveries create more predictable outcomes - but only if used in the office.

ADHD is the most frequently misunderstood, misdiagnosed and mistreated psychiatric condition on the planet--and fresh neuroscience spells out the underlying details for improved, more predictable recovery. With New Rules the reader can participate in these next essential changed changes for ADHD medical care.

From the Back Cover

New ADHD Medication Rules is based upon the latest brain science, and includes a variety of associated treatment topics that address the real complexity of ADHD medical management.

The variables that effect medication effectiveness range from sleep, to breakfast, to biomedical interferences that can dramatically change the way medications burn in the body. Without New Rules the possibility of missing potentially dangerous drug interactions and associated diagnostic challenges, such as depression and anxiety, adds to the greater possibility of treatment failure.

A key objective for New Rules: engaging your medical team in more participatory dialogue with more clear expectations for medication outcomes and improved discussion at every medication check.

About the Author

Dr Charles Parker, a neuroscience consultant and practicing child and adult psychiatrist, has lectured nationally for 20 years on the applications of ADHD medications, is an award winning citizen journalist at CorePsych, the author of Deep Recovery (1992) and teaches both professionals and the public how to use available neuroscience evidence at CoreBrain Training. Dr Parker is certified by the Nuclear Regulatory Commission to provide SPECT functional brain imaging, and routinely uses advanced neurotransmitter, endocrine, immune, and trace element laboratory assessments to evaluate complex ADHD presentations.